Table 3.

Clinical response at EOI for MRD-negative patients

Clinical response at EOI MRD negative at EOI (N = 13)
IRC assessed, n (%)  
CR 11 (84.6) 
PR 1 (7.7) 
NA 1 (7.7) 
Investigator assessed, n (%)  
CR 11 (84.6) 
PR 1 (7.7) 
NA 1 (7.7) 
Clinical response at EOI MRD negative at EOI (N = 13)
IRC assessed, n (%)  
CR 11 (84.6) 
PR 1 (7.7) 
NA 1 (7.7) 
Investigator assessed, n (%)  
CR 11 (84.6) 
PR 1 (7.7) 
NA 1 (7.7) 

NA, not available.

Assessed according to the modified Lugano 2014 criteria.

Patients were MRD positive at baseline and had repeated testing at EOI; all were negative at EOI.

or Create an Account

Close Modal
Close Modal